The Scientist

» BRCA2 and immunology

Most Recent

image: Antifungal Permits Flu?

Antifungal Permits Flu?

By | November 21, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

0 Comments

image: Gut Flora Boost Cancer Therapies

Gut Flora Boost Cancer Therapies

By | November 21, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

2 Comments

image: HIV’s Stealth Revealed

HIV’s Stealth Revealed

By | November 21, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

2 Comments

image: T cells and Transplantation

T cells and Transplantation

By | November 13, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

0 Comments

image: Time for T cells

Time for T cells

By | November 7, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

1 Comment

image: Newborn Immune Systems Suppressed

Newborn Immune Systems Suppressed

By | November 6, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

1 Comment

image: Frisky Fruit Flies

Frisky Fruit Flies

By | November 5, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

1 Comment

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

4 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

0 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2013

A common fungus-fighting drug increases the susceptibility of mice to influenza infections.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech